The board of JSW Steel Ltd has approved the company’s participation in the proposed IPO of JSW One Platforms Ltd (JOPL) as a promoter selling shareholder. The company plans to sell equity shares worth up to ₹811 crore through an offer for sale (OFS).
Alembic Pharmaceuticals said its partner NATCO Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Olaparib Tablets in 100 mg and 150 mg strengths, a generic equivalent of AstraZeneca’s Lynparza tablets. The approval is for the indication covered under the approved labelling of the reference listed drug. Alembic Pharmaceuticals will distribute the product in the United States, while NATCO Pharma will manufacture.
An inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of Cipla Limited) located in Central Islip, Long Island, New York, USA, from July 13 to 17. The inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. On conclusion of the inspection, the company has received one)inspectional observation in Form 483. The Company will work closely with the USFDA and is committed to address this comprehensively within stipulated time.
Laser Power & Infra Ltd on Sunday said it has secured a Rs 4.15 crore order from Himachal Pradesh State Electricity Board Limited for the supply and installation of advanced conductors. The Kolkata-based company said the project entails replacing conventional conductors with advanced high-temperature low-sag conductors that significantly enhance transmission capacity while utilising the existing tower infrastructure.
Discount broker 5paisa Capital Ltd has partnered with OpenAI to integrate advanced artificial intelligence across the investing and trading journey, bringing personalised insights and advisory support to its retail investors.
Prestige Estates Projects Ltd has launched three housing projects during the April-June quarter with an estimated revenue of Rs 12,000 crore, as part of its expansion plan amid strong demand. In its latest operational update, Bengaluru-based Prestige Estates Projects informed that the company launched four projects with a combined developable area of 20.16 million square feet. Out of four projects, three are residential properties in Hyderabad, Bengaluru and Mumbai. One commercial project with a developable area of 3 million sq ft is in Bengaluru. The company said the total revenue potential for these three residential projects is estimated at Rs 12,000 crore.
CRISIL Ratings has upgraded the long-term credit ratings of key Vedanta Group companies following the group’s demerger, assigning a Stable outlook. The upgrades reflect stronger standalone business profiles, improved financial flexibility and lower structural complexity after the restructuring.